Atlas Trials

SHR-1210 Combined With Apatinib Mesylate in the Perioperative Therapy for Hepatocellular Carcinoma

Clinical trial NCT04930315 · COMPLETED

Trial details

NCT number
NCT04930315
Sponsor
Zhejiang University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2021-09-15
Primary completion
2024-05-16
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.